化学抗原受体T细胞治疗后的恶性病变
Razan Mohty1, Amal Halwani2, Talha Badar3
1Division of Hematology-Oncology and O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama.
Transplantation and cellular therapy
|June 7, 2025
概括
卡特-T细胞疗法对某些血液癌症具有显著的益处,但存在第二次原发性恶性瘤的风险. 目前正在进行的研究旨在澄清CAR-T疗法对这些风险的确切贡献.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 卡尔-T细胞疗法是针对复发性/耐药性 (R/R) B 细胞恶性瘤的开创性治疗方法.
- 在CAR-T治疗后,人们对第二次原发性恶性瘤 (SPMs) 的发展产生了担忧.
研究的目的:
- 审查SPM的发病率和特征,包括 CAR-T 治疗后的第二个髓状瘤 (SMN) 和第二个非血液性恶性瘤 (SNHM) 以及T细胞癌症.
- 在潜在的SPM的背景下评估CAR-T细胞治疗的风险-益处概况.
主要方法:
- 在CAR-T细胞治疗后报告SPM的研究文献综述.
- 对SMN,SNHM和T细胞恶性瘤的发病率的分析.
- 讨论可能导致SPM发展的因素.
主要成果:
- SPM的发病率在2.3%至11.3%之间,老年患者和接受过广泛治疗的患者的发病率更高.
- SMNs (例如,骨髓质疏松症候群) 和SNHMs发生的频率各不相同.
- T细胞癌很罕见 (0.03%1%),对CAR-T疗法具有挑战性的因果归因.
结论:
- 针对特定的血液性恶性瘤,CAR-T细胞治疗的治疗优势目前超过了SPM的观察到的风险.
- 需要进行进一步的研究,以区分CAR-T疗法的影响与其他有助于SPM发展的因素.
更多相关视频
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.5K
06:51Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
15.3K
相关概念视频
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
